Xbrane Biopharma

Major Shareholding Notification • Aug 31, 2023

Issuer Xbrane Biopharma AB

Holder

Teknik Innovation Norden AB

Instrument

Instrument Xbrane Biopharma AB SE0007789409 Before the transaction Shares 1,553,055 Voting rights 1,553,055 Transaction Reason for major shareholding notification Sell Date 29/08/2023 Limit for number of shares 5 % Limit for number of votes 5 % After the transaction Quantity Shares 1,415,055 Directly held voting rights 1,415,055 Indirectly held voting rights 0 Percentage Directly held shares 4.84 % Directly held voting rights 4.84 % Indirectly held voting rights 0 %

Resulting distribution of total holdings

		Percentage of voting rights:	Number of underlying shares:
Shares		4.84 %	1,415,055
	Instruments - FITA Ch. 4, section 2, first paragraph, line 2
	Instruments - FITA Ch. 4, section 2, first paragraph, line 3
	- Physically settled
	- Cash settled
Total		4.84 %	1,415,055
Published
	31/08/2023 19:10
Contact
Name	Tomas Lundmark
Phone	0721439908	Email tomas.lundmark@tinfonder.se

CLOSE PRINT

rapportering@fi.se Tfn 08-408 980 37 Fax 08-24 39 25